Dr. Manash K Paul

Associate Professor

Department of Radiation Biology and Toxicology

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    • Manash K. Paul is an Associate Professor in the Department of Radiation Biology and Toxicology at the 沙巴体育 School of Life Sciences.?
    • 沙巴体育 Area: Stem cell, Regenerative medicine, and Cancer
    • Guides doctoral, post-graduate, and graduate students for various research projects

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
PhD Biotechnology National Institute of Pharmaceutical Education and 沙巴体育, Mohali (NIPER-M) 2008
MSc Biotechnology Visva Bharati University, An Institute of National Importance Shantiniketan, West Bengal 2001

Experience

Institution / Organisation Designation Role Tenure
沙巴体育 School of Life Sciences, 沙巴体育 Academy of Higher Education Associate Professor 19.10.2023 Till date
Kasturba Medical College, 沙巴体育 Academy of Higher Education Adjunct Faculty 12.11.2022 to 18.10.2023
Department of Pulmonary and Critical Care Medicine, University of California, Los Angeles (UCLA), USA. Assistant Project Scientist Step IV (Group ID: FACULTY) 01.07.2020 to 22.09.2023
Department of Pulmonary and Critical Care Medicine, UCLA, USA. Assistant Project Scientist Step I and II 01.07.2016 to 30.06.2020
Brigitte Gompert’s Laboratory, University of California, Los Angeles (UCLA), USA. Post Doctoral Fellow 01.05.2012 to 05.04.2016
Volker Hartenstein’s Laboratory, University of California, Los Angeles (UCLA), USA. Post Doctoral Fellow 10.03.2010 to 31.04.2012
Indian Institute of Science Education and 沙巴体育 (IISERM), Institute of National Importance, Mohali, India Lecturer 05.09.2007 to 01.03.20

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Expertise

Stem cell, Regenerative medicine, and Cancer

Area of 沙巴体育

Stem cell biology in mouse and human, iPSC, ASCs, ADSCs, MSCs, directed differentiation. Organoid technology (lung, gut, brain, and pancreas), spheroids, tumoroids, tissue engineering, disease modeling, drug screening, Microfluidic Organoids-on-a-Chip technology, drug discovery, assay development. CRISPR-Cas9. o Mouse models for studying lung disease, mouse genetics, Cre-LoxP system, transgenic models, syngeneic mouse models, patient-derived xenograft models, adenocarcinoma and squamous lung cancer models, fibrosis, COPD, injury and metastatic models.